Open AccessAcquired von Willebrand syndrome and lymphoproliferative disorders: A case report
Author(s) -
Nicol Christophe,
Raj Leela,
Guillerm Gaëlle,
Couturaud Francis,
Eveillard JeanRichard,
PanPetesch Brigitte
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2770
Subject(s) - medicine , daratumumab , discontinuation , lymphoproliferative disorders , dermatology , multiple myeloma , pediatrics , immunology , bortezomib , lymphoma
Acquired von Willebrand syndrome is a rare bleeding disorder often secondary to an underlying lymphoproliferative disorder. We report a case in whom response of both the acquired von Willebrand syndrome and smoldering multiple myeloma persist 14 months after daratumumab treatment discontinuation.